Ontology type: schema:ScholarlyArticle Open Access: True
2019-03-29
AUTHORSRomain Guilhaumou, Sihem Benaboud, Youssef Bennis, Claire Dahyot-Fizelier, Eric Dailly, Peggy Gandia, Sylvain Goutelle, Sandrine Lefeuvre, Nicolas Mongardon, Claire Roger, Julien Scala-Bertola, Florian Lemaitre, Marc Garnier
ABSTRACTBackgroundBeta-lactam antibiotics (βLA) are the most commonly used antibiotics in the intensive care unit (ICU). ICU patients present many pathophysiological features that cause pharmacokinetic (PK) and pharmacodynamic (PD) specificities, leading to the risk of underdosage. The French Society of Pharmacology and Therapeutics (SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (SFAR) have joined forces to provide guidelines on the optimization of beta-lactam treatment in ICU patients.MethodsA consensus committee of 18 experts from the two societies had the mission of producing these guidelines. The entire process was conducted independently of any industry funding. A list of questions formulated according to the PICO model (Population, Intervention, Comparison, and Outcomes) was drawn-up by the experts. Then, two bibliographic experts analysed the literature published since January 2000 using predefined keywords according to PRISMA recommendations. The quality of the data identified from the literature was assessed using the GRADE® methodology. Due to the lack of powerful studies having used mortality as main judgement criteria, it was decided, before drafting the recommendations, to formulate only “optional” recommendations.ResultsAfter two rounds of rating and one amendment, a strong agreement was reached by the SFPT-SFAR guideline panel for 21 optional recommendations and a recapitulative algorithm for care covering four areas: (i) pharmacokinetic variability, (ii) PK-PD relationship, (iii) administration modalities, and (iv) therapeutic drug monitoring (TDM). The most important recommendations regarding βLA administration in ICU patients concerned (i) the consideration of the many sources of PK variability in this population; (ii) the definition of free plasma concentration between four and eight times the Minimal Inhibitory Concentration (MIC) of the causative bacteria for 100% of the dosing interval as PK-PD target to maximize bacteriological and clinical responses; (iii) the use of continuous or prolonged administration of βLA in the most severe patients, in case of high MIC bacteria and in case of lower respiratory tract infection to improve clinical cure; and (iv) the use of TDM to improve PK-PD target achievement.ConclusionsThe experts strongly suggest the use of personalized dosing, continuous or prolonged infusion and therapeutic drug monitoring when administering βLA in critically ill patients. More... »
PAGES104
http://scigraph.springernature.com/pub.10.1186/s13054-019-2378-9
DOIhttp://dx.doi.org/10.1186/s13054-019-2378-9
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1113107158
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30925922
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Anti-Bacterial Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Critical Illness",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Dosage Calculations",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Monitoring",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "France",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glomerular Filtration Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Guidelines as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Intensive Care Units",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Serum Albumin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Societies, Medical",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Societies, Pharmaceutical",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "beta-Lactamases",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "AP-HM H\u00f4pital de la Timone, Service de Pharmacologie Clinique et Pharmacovigilance, 264 rue Saint Pierre, 13005, Marseille, France",
"id": "http://www.grid.ac/institutes/None",
"name": [
"AP-HM H\u00f4pital de la Timone, Service de Pharmacologie Clinique et Pharmacovigilance, 264 rue Saint Pierre, 13005, Marseille, France"
],
"type": "Organization"
},
"familyName": "Guilhaumou",
"givenName": "Romain",
"id": "sg:person.01205666273.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205666273.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP H\u00f4pital Cochin, Service de Pharmacologie, 27 rue du Faubourg St-Jacques, 75679, Paris Cedex 14, France",
"id": "http://www.grid.ac/institutes/None",
"name": [
"AP-HP H\u00f4pital Cochin, Service de Pharmacologie, 27 rue du Faubourg St-Jacques, 75679, Paris Cedex 14, France"
],
"type": "Organization"
},
"familyName": "Benaboud",
"givenName": "Sihem",
"id": "sg:person.01032325745.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032325745.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU d\u2019Amiens Picardie, Service de Pharmacologie Clinique, UPJV EA7517, Avenue Laennec, 80054, Amiens Cedex 1, France",
"id": "http://www.grid.ac/institutes/grid.413858.3",
"name": [
"CHU d\u2019Amiens Picardie, Service de Pharmacologie Clinique, UPJV EA7517, Avenue Laennec, 80054, Amiens Cedex 1, France"
],
"type": "Organization"
},
"familyName": "Bennis",
"givenName": "Youssef",
"id": "sg:person.01203524231.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203524231.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU de Poitiers, D\u00e9partement d\u2019Anesth\u00e9sie R\u00e9animation, 2 Rue de la Mil\u00e9trie, 86021, Poitiers, France",
"id": "http://www.grid.ac/institutes/grid.411162.1",
"name": [
"CHU de Poitiers, D\u00e9partement d\u2019Anesth\u00e9sie R\u00e9animation, 2 Rue de la Mil\u00e9trie, 86021, Poitiers, France"
],
"type": "Organization"
},
"familyName": "Dahyot-Fizelier",
"givenName": "Claire",
"id": "sg:person.01352406745.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352406745.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU de Nantes, D\u00e9partement de Pharmacologie Clinique, 5 all\u00e9e de l\u2019\u00eele gloriette, 44093, Nantes Cedex 01, France",
"id": "http://www.grid.ac/institutes/grid.277151.7",
"name": [
"CHU de Nantes, D\u00e9partement de Pharmacologie Clinique, 5 all\u00e9e de l\u2019\u00eele gloriette, 44093, Nantes Cedex 01, France"
],
"type": "Organization"
},
"familyName": "Dailly",
"givenName": "Eric",
"id": "sg:person.01065077071.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065077071.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU de Toulouse, Laboratoire de Pharmacocin\u00e9tique et Toxicologie Clinique, Institut F\u00e9d\u00e9ratif de Biologie, 330, avenue de Grande-Bretagne, 31059, Toulouse cedex 9, France",
"id": "http://www.grid.ac/institutes/grid.411175.7",
"name": [
"CHU de Toulouse, Laboratoire de Pharmacocin\u00e9tique et Toxicologie Clinique, Institut F\u00e9d\u00e9ratif de Biologie, 330, avenue de Grande-Bretagne, 31059, Toulouse cedex 9, France"
],
"type": "Organization"
},
"familyName": "Gandia",
"givenName": "Peggy",
"id": "sg:person.01311772632.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311772632.70"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU de Lyon, Service de Pharmacie, Groupement Hospitalier Nord, H\u00f4pital Pierre Garraud, 136 rue du Commandant Charcot, 69322, Lyon cedex 05, France",
"id": "http://www.grid.ac/institutes/grid.413852.9",
"name": [
"CHU de Lyon, Service de Pharmacie, Groupement Hospitalier Nord, H\u00f4pital Pierre Garraud, 136 rue du Commandant Charcot, 69322, Lyon cedex 05, France"
],
"type": "Organization"
},
"familyName": "Goutelle",
"givenName": "Sylvain",
"id": "sg:person.01111665536.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111665536.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHR d\u2019Orl\u00e9ans, Laboratoire de Biochimie, 14 Avenue de l\u2019H\u00f4pital, 45067, Orl\u00e9ans, France",
"id": "http://www.grid.ac/institutes/None",
"name": [
"CHR d\u2019Orl\u00e9ans, Laboratoire de Biochimie, 14 Avenue de l\u2019H\u00f4pital, 45067, Orl\u00e9ans, France"
],
"type": "Organization"
},
"familyName": "Lefeuvre",
"givenName": "Sandrine",
"id": "sg:person.0664453716.41",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664453716.41"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP H\u00f4pital Henri Mondor, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, 51 Avenue du Mar\u00e9chal de Lattre de Tassigny, 94000, Cr\u00e9teil, France",
"id": "http://www.grid.ac/institutes/None",
"name": [
"AP-HP H\u00f4pital Henri Mondor, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, 51 Avenue du Mar\u00e9chal de Lattre de Tassigny, 94000, Cr\u00e9teil, France"
],
"type": "Organization"
},
"familyName": "Mongardon",
"givenName": "Nicolas",
"id": "sg:person.01216312122.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216312122.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU de N\u00eemes, D\u00e9partement d\u2019anesth\u00e9sie, r\u00e9animation, douleur et m\u00e9dicine d\u2019urgence, Place du Pr Robert Debr\u00e9, 30029, N\u00eemes cedex 9, France",
"id": "http://www.grid.ac/institutes/grid.411165.6",
"name": [
"CHU de N\u00eemes, D\u00e9partement d\u2019anesth\u00e9sie, r\u00e9animation, douleur et m\u00e9dicine d\u2019urgence, Place du Pr Robert Debr\u00e9, 30029, N\u00eemes cedex 9, France"
],
"type": "Organization"
},
"familyName": "Roger",
"givenName": "Claire",
"id": "sg:person.0604417143.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604417143.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHRU de Nancy, D\u00e9partement de pharmacologie clinique et de toxicologie, 29 rue Lionnois, 54000, Nancy, France",
"id": "http://www.grid.ac/institutes/grid.410527.5",
"name": [
"CHRU de Nancy, D\u00e9partement de pharmacologie clinique et de toxicologie, 29 rue Lionnois, 54000, Nancy, France"
],
"type": "Organization"
},
"familyName": "Scala-Bertola",
"givenName": "Julien",
"id": "sg:person.01302555643.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302555643.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CHU Pontchaillou, Service de Pharmacologie Clinique et \u00e9pid\u00e9miologique, 2 Rue Henri le Guilloux, 35000, Rennes, France",
"id": "http://www.grid.ac/institutes/grid.414271.5",
"name": [
"CHU Pontchaillou, Service de Pharmacologie Clinique et \u00e9pid\u00e9miologique, 2 Rue Henri le Guilloux, 35000, Rennes, France"
],
"type": "Organization"
},
"familyName": "Lemaitre",
"givenName": "Florian",
"id": "sg:person.01110354341.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110354341.05"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP H\u00f4pital Tenon, D\u00e9partement d\u2019Anesth\u00e9sie et R\u00e9animation, 4 rue de la Chine, 75020, Paris, France",
"id": "http://www.grid.ac/institutes/grid.50550.35",
"name": [
"AP-HP H\u00f4pital Tenon, D\u00e9partement d\u2019Anesth\u00e9sie et R\u00e9animation, 4 rue de la Chine, 75020, Paris, France"
],
"type": "Organization"
},
"familyName": "Garnier",
"givenName": "Marc",
"id": "sg:person.07443737243.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07443737243.21"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/s13613-015-0093-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026015877",
"https://doi.org/10.1186/s13613-015-0093-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/11318140-000000000-00000",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039277611",
"https://doi.org/10.2165/11318140-000000000-00000"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s13318-017-0439-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1092187076",
"https://doi.org/10.1007/s13318-017-0439-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/11539220-000000000-00000",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045065825",
"https://doi.org/10.2165/11539220-000000000-00000"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00134-015-4188-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029454839",
"https://doi.org/10.1007/s00134-015-4188-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40264-017-0578-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1090909191",
"https://doi.org/10.1007/s40264-017-0578-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10096-016-2832-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029650859",
"https://doi.org/10.1007/s10096-016-2832-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc9091",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031159164",
"https://doi.org/10.1186/cc9091"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc10257",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005923181",
"https://doi.org/10.1186/cc10257"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc8941",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040862782",
"https://doi.org/10.1186/cc8941"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40262-012-0018-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026024203",
"https://doi.org/10.1007/s40262-012-0018-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13054-018-2155-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1107133834",
"https://doi.org/10.1186/s13054-018-2155-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1067/mcp.2002.121829",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044113659",
"https://doi.org/10.1067/mcp.2002.121829"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2334-11-181",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017207082",
"https://doi.org/10.1186/1471-2334-11-181"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc10441",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037453353",
"https://doi.org/10.1186/cc10441"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13054-017-1856-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1092690158",
"https://doi.org/10.1186/s13054-017-1856-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/00003088-200847030-00003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033831230",
"https://doi.org/10.2165/00003088-200847030-00003"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc12544",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041305613",
"https://doi.org/10.1186/cc12544"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc13094",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023558979",
"https://doi.org/10.1186/cc13094"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/00003088-200039050-00003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033874588",
"https://doi.org/10.2165/00003088-200039050-00003"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc11862",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017822371",
"https://doi.org/10.1186/cc11862"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01712162",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038871033",
"https://doi.org/10.1007/bf01712162"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00134-013-3187-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016715841",
"https://doi.org/10.1007/s00134-013-3187-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40005-013-0073-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047074920",
"https://doi.org/10.1007/s40005-013-0073-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2110-5820-2-35",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020507376",
"https://doi.org/10.1186/2110-5820-2-35"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11096-016-0334-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020337346",
"https://doi.org/10.1007/s11096-016-0334-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/11319370-000000000-00000",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045903643",
"https://doi.org/10.2165/11319370-000000000-00000"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13054-016-1255-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012708353",
"https://doi.org/10.1186/s13054-016-1255-z"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-03-29",
"datePublishedReg": "2019-03-29",
"description": "BackgroundBeta-lactam antibiotics (\u03b2LA) are the most commonly used antibiotics in the intensive care unit (ICU). ICU patients present many pathophysiological features that cause pharmacokinetic (PK) and pharmacodynamic (PD) specificities, leading to the risk of underdosage. The French Society of Pharmacology and Therapeutics (SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (SFAR) have joined forces to provide guidelines on the optimization of beta-lactam treatment in ICU patients.MethodsA consensus committee of 18 experts from the two societies had the mission of producing these guidelines. The entire process was conducted independently of any industry funding. A list of questions formulated according to the PICO model (Population, Intervention, Comparison, and Outcomes) was drawn-up by the experts. Then, two bibliographic experts analysed the literature published since January 2000 using predefined keywords according to PRISMA recommendations. The quality of the data identified from the literature was assessed using the GRADE\u00ae methodology. Due to the lack of powerful studies having used mortality as main judgement criteria, it was decided, before drafting the recommendations, to formulate only \u201coptional\u201d recommendations.ResultsAfter two rounds of rating and one amendment, a strong agreement was reached by the SFPT-SFAR guideline panel for 21 optional recommendations and a recapitulative algorithm for care covering four areas: (i) pharmacokinetic variability, (ii) PK-PD relationship, (iii) administration modalities, and (iv) therapeutic drug monitoring (TDM). The most important recommendations regarding \u03b2LA administration in ICU patients concerned (i) the consideration of the many sources of PK variability in this population; (ii) the definition of free plasma concentration between four and eight times the Minimal Inhibitory Concentration (MIC) of the causative bacteria for 100% of the dosing interval as PK-PD target to maximize bacteriological and clinical responses; (iii) the use of continuous or prolonged administration of \u03b2LA in the most severe patients, in case of high MIC bacteria and in case of lower respiratory tract infection to improve clinical cure; and (iv) the use of TDM to improve PK-PD target achievement.ConclusionsThe experts strongly suggest the use of personalized dosing, continuous or prolonged infusion and therapeutic drug monitoring when administering \u03b2LA in critically ill patients.",
"genre": "article",
"id": "sg:pub.10.1186/s13054-019-2378-9",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1117766",
"issn": [
"1364-8535",
"1466-609X"
],
"name": "Critical Care",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "23"
}
],
"keywords": [
"therapeutic drug monitoring",
"intensive care unit",
"intensive care medicine",
"ICU patients",
"minimal inhibitory concentration",
"care medicine",
"use of TDM",
"drug monitoring",
"lower respiratory tract infections",
"PK-PD targets",
"respiratory tract infections",
"free plasma concentrations",
"PK-PD relationship",
"beta-lactam treatment",
"main judgment criterion",
"beta-lactam antibiotics",
"pharmacodynamic specificity",
"risk of underdosage",
"clinical cure",
"clinical response",
"tract infections",
"severe patients",
"ill patients",
"care unit",
"French Society",
"pathophysiological features",
"pharmacokinetic variability",
"guideline panel",
"prolonged administration",
"prolonged infusion",
"PK variability",
"plasma concentrations",
"causative bacteria",
"administration modalities",
"PICO model",
"PRISMA recommendations",
"patients",
"personalized dosing",
"consensus committee",
"ConclusionsThe experts",
"inhibitory concentration",
"anesthesia",
"optional recommendations",
"antibiotics",
"powerful studies",
"administration",
"pharmacology",
"target achievement",
"treatment",
"industry funding",
"therapeutics",
"two-round",
"medicine",
"guidelines",
"recommendations",
"infusion",
"dosing",
"mortality",
"infection",
"care",
"strong agreement",
"cure",
"underdosage",
"modalities",
"risk",
"cases",
"use",
"important recommendations",
"grade",
"population",
"concentration",
"bacteria",
"specificity",
"monitoring",
"response",
"interval",
"list of questions",
"target",
"literature",
"experts",
"Committee",
"criteria",
"judgment criteria",
"study",
"lack",
"variability",
"ratings",
"panel",
"keywords",
"rounds",
"society",
"data",
"quality",
"list",
"relationship",
"funding",
"units",
"time",
"features",
"area",
"definition",
"questions",
"consideration",
"model",
"source",
"entire process",
"achievement",
"process",
"force",
"agreement",
"methodology",
"optimization",
"amendments",
"mission",
"algorithm"
],
"name": "Optimization of the treatment with beta-lactam antibiotics in critically ill patients\u2014guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique\u2014SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et R\u00e9animation\u2014SFAR)",
"pagination": "104",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1113107158"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s13054-019-2378-9"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30925922"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s13054-019-2378-9",
"https://app.dimensions.ai/details/publication/pub.1113107158"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:36",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_822.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s13054-019-2378-9"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13054-019-2378-9'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13054-019-2378-9'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13054-019-2378-9'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13054-019-2378-9'
This table displays all metadata directly associated to this object as RDF triples.
462 TRIPLES
22 PREDICATES
183 URIs
147 LITERALS
21 BLANK NODES